Worth reading
52Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Deterioration
Direction inferred from the company’s description.Scale
-709
¥ millions (year-on-year change in operating income)Wording
Conditional
How definitive the wording is.Contents of this document
Earnings presentationFirst quarter of the fiscal year ending March 20277 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales14,382 million yen-1.2%
Operating profit622 million yen-53.2%
Ordinary income784 million yen-45.3%
Net income¥432 million -45.6%profit attributable to owners of the parent
Selling, general and administrative expenses5,900 million yen
Gross Profit Margin
Rate45.4
Year-on-year change (points)0.1
Operating profit margin
Rate4.3
Year-on-year change (points)-4.9
Results for the three months of the current quarter
Net Sales
14,382 million yen
Operating profit
622 million yen
Ordinary income
784 million yen
Profit before income taxes
743 million yen
Profit attributable to owners of parent for the quarter
432 million yen
Full-year earnings forecast
Net Sales
68,000 million yen
Operating profit
7,000 million yen
Ordinary income
6,900 million yen
Profit attributable to owners of the parent
4,500 million yen
Earnings per share
164.31 yen
Progress against full-year forecast 通期の予想に対して、いまどこまで進んだかの割合です。
Net Sales21.2
Operating profit8.9
Ordinary income11.4
Profit attributable to owners of the parent9.6
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Progress in line with the full-year forecastBreakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Demand adjustments in the semiconductor-related business, fewer projects recognized as revenue, demand for weighing instruments and large measurement equipment orders in the measurement and weighing instruments business, tariff costs in the Americas and higher SG&A expenses, increased overseas shipment volumes in the medical and healthcare equipment business, expanded sales of products for major customers and products supporting medical digital transformation, pricing optimization, and foreign exchange effects. Amounts by factor: Not disclosed.
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
Assumed Exchange Rates
US$1150
Russian ruble1.9
New initiatives
- Making 株式会社エーディーシー a subsidiary through the acquisition of all sharesImplementation Date10 July 2026DetailsMutual utilization of 株式会社エーディーシー's technologies, product portfolio and customer base for electronic and optical measuring instruments with the Group's measurement technologies, production base and global sales network
Key KPIsA metric the company considers important as a management benchmark.
- Order backlog in the semiconductor-related business4,809 million yenYear on year against the same period last year-36.1%
- Order backlog in the measurement and weighing instruments business5,795 million yenYear on year against the same period last year-14.5%
- Order backlog in the medical and healthcare equipment business449 million yenYear on year against the same period last year-4.3%
Segment results
- Semiconductor-Related BusinessNet Sales897 million yen (YoY -68.9%)Operating profit-122 million yenOrder backlog4,809 million yen (YoY -36.1%)
- Measurement and weighing instruments businessNet Sales6,779 million yen (YoY +8.8%)Operating profit170 million yen (YoY +201.9%)Order backlog5,795 million yen (YoY -14.5%)
- Medical and healthcare equipment businessNet Sales6,705 million yen (YoY +23.3%)Operating profit1,134 million yen (YoY +86.4%)Order backlog449 million yen (YoY -4.3%)
Orders received and order backlog
Semiconductor-Related Business
4,809 million yen
Measurement and weighing instruments business
5,795 million yen
Medical and healthcare equipment business
449 million yen
| Item | Details |
|---|---|
| Document type | Earnings presentation |
| Fiscal Period Covered | First quarter of the fiscal year ending March 2027 |
| Net Sales | 14,382 million yen (YoY -1.2%) |
| Operating profit | 622 million yen (YoY -53.2%) |
| Ordinary income | 784 million yen (YoY -45.3%) |
| Net income | ¥432 million (profit attributable to owners of the parent) (YoY -45.6%) |
| Gross Profit Margin | Rate 45.4 / Year-on-year change (points) 0.1 |
| Operating profit margin | Rate 4.3 / Year-on-year change (points) -4.9 |
| Selling, general and administrative expenses | 5,900 million yen |
| Results for the three months of the current quarter | Net Sales 14,382 million yen / Operating profit 622 million yen / Ordinary income 784 million yen / Profit before income taxes 743 million yen / Profit attributable to owners of parent for the quarter 432 million yen |
| Full-year earnings forecast | Net Sales 68,000 million yen / Operating profit 7,000 million yen / Ordinary income 6,900 million yen / Profit attributable to owners of the parent 4,500 million yen / Earnings per share 164.31 yen |
| Progress against full-year forecast | Net Sales 21.2 / Operating profit 8.9 / Ordinary income 11.4 / Profit attributable to owners of the parent 9.6 |
| Self-assessment against the plan | Progress in line with the full-year forecast |
| Segment results | Segment Semiconductor-Related Business / Net Sales 897 million yen (YoY -68.9%) / Operating profit -122 million yen / Order backlog 4,809 million yen (YoY -36.1%), Segment Measurement and weighing instruments business / Net Sales 6,779 million yen (YoY +8.8%) / Operating profit 170 million yen (YoY +201.9%) / Order backlog 5,795 million yen (YoY -14.5%), Segment Medical and healthcare equipment business / Net Sales 6,705 million yen (YoY +23.3%) / Operating profit 1,134 million yen (YoY +86.4%) / Order backlog 449 million yen (YoY -4.3%) |
| Breakdown of Factors Affecting the Change | Demand adjustments in the semiconductor-related business, fewer projects recognized as revenue, demand for weighing instruments and large measurement equipment orders in the measurement and weighing instruments business, tariff costs in the Americas and higher SG&A expenses, increased overseas shipment volumes in the medical and healthcare equipment business, expanded sales of products for major customers and products supporting medical digital transformation, pricing optimization, and foreign exchange effects. Amounts by factor: Not disclosed. |
| Key KPIs | Indicator name Order backlog in the semiconductor-related business / Value 4,809 million yen / Year on year against the same period last year -36.1 million yen, Indicator name Order backlog in the measurement and weighing instruments business / Value 5,795 million yen / Year on year against the same period last year -14.5 million yen, Indicator name Order backlog in the medical and healthcare equipment business / Value 449 million yen / Year on year against the same period last year -4.3 million yen |
| Assumptions Underlying the Business Outlook | Assumed Exchange Rates US$1 150 / Russian ruble 1.9 |
| Orders received and order backlog | Semiconductor-Related Business 4,809 million yen / Measurement and weighing instruments business 5,795 million yen / Medical and healthcare equipment business 449 million yen |
| New initiatives | Measures Making 株式会社エーディーシー a subsidiary through the acquisition of all shares / Implementation Date 10 July 2026 / Details Mutual utilization of 株式会社エーディーシー's technologies, product portfolio and customer base for electronic and optical measuring instruments with the Group's measurement technologies, production base and global sales network |
Items this document does not state (12)
Unit price and quantity metricsNumber of stores and locationsNumber of employeesRisk amount incorporated into the outlookMedium-term management plan targetsFinancial targetsAnnual DividendPayout ratioAcquisition of treasury sharesCapital expendituresMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Demand adjustments continued in the semiconductor-related business, resulting in fewer projects recognized as revenue. In the measurement and weighing instruments business, tariff costs in the Americas and higher SG&A expenses affected profit, while in the medical and healthcare equipment business, overseas tariff costs and higher selling costs had an impact. Demand and sales growth in Japan and Asia, among other regions, contributed to higher profit.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.